We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
List of words and phrases that will cause a veterinary product to be medicinal by presentation either through use or contextual use.
List of substances recognised as medicinal by function.
Guidance for the pharmaceutical industry on Marketing Authorisations for veterinary medicines in the UK.
Placing a veterinary medicine on the market, including non-medicinal products, how to obtain advice and report non-compliance.
How to use a budget impact analysis to evaluate your digital health product.
Explainer for the rules for advertising products used in, on or near animals that are not licensed veterinary medicines.
Urgent and clinically significant safety updates arising from pharmacovigilance data, including reported adverse events, for veterinary medicines authorised in the UK.
Information on applying for New Active Substance Work Sharing Initiative (NASWSI) and Biosimilar Work Sharing Initiative (BSWSI) assessments and list of approved products.
You must include the appropriate legal basis for your application when you apply to MHRA for a marketing authorisation.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).